Literature DB >> 2797219

Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors.

M Ströher1, C Nanoff, W Schütz.   

Abstract

Using [3H]8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a 3H-labeled A1-selective adenosine antagonist with high affinity and extremely low non-specific binding, it was possible to quantitatively evaluate the effect of GTP on agonist binding. Competition experiments on [3H]DPCPX binding to guinea-pig cerebral cortical membranes in the absence of GTP showed a high- and a low-affinity state for adenosine receptor agonists (82/18% for N6-cyclopentyl-adenosine). Addition of 1 mmol/l GTP only partially converted the high-affinity state of the A1-adenosine receptor into a low-affinity state. This failure of complete conversion from high- to low-affinity state was also seen in membranes from rat testes under the same experimental conditions and, moreover, in guinea-pig brain membranes under different experimental conditions, such as in the presence of Na+ or when free Mg2+ has been reduced by EDTA. The only difference was that in the absence of Mg2+ the high-affinity state of the A1-receptor was markedly smaller than in the presence of Mg2+ (36% vs. 82%). By contrast, in the solubilized state of the receptor total conversion of all receptors into the low-affinity state was obtained upon addition of 1 mmol/l GTP. Reduction of binding of the agonist radioligand [125]iodo-N6-(4-hydroxyphenylisopropyl)-adenosine with increasing concentrations of GTP and Gpp(NH)p demonstrated that the guanine nucleotide affinity to the solubilized A1-receptor was more than 100-fold higher than to the membrane-bound receptor. Hence, the incomplete transition of the high-affinity into the low-affinity state of the membrane-bound A1-receptor upon addition of GTP may be attributable to the low affinity of the membrane-bound receptor-G-protein complex for GTP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797219     DOI: 10.1007/bf00169212

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

2.  Solubilized adenosine receptors in the brain: regulation of guanine nucleotides.

Authors:  M Gavish; R R Goodman; S H Snyder
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

3.  Characterization of the solubilized A1 adenosine receptor from rat brain membranes.

Authors:  K N Klotz; M J Lohse; U Schwabe
Journal:  J Neurochem       Date:  1986-05       Impact factor: 5.372

4.  Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.

Authors:  M J Lohse; V Lenschow; U Schwabe
Journal:  Mol Pharmacol       Date:  1984-07       Impact factor: 4.436

5.  Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.

Authors:  R R Goodman; M J Cooper; M Gavish; S H Snyder
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

6.  Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.

Authors:  V Ramkumar; G L Stiles
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

7.  Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding.

Authors:  J Linden
Journal:  Mol Pharmacol       Date:  1984-11       Impact factor: 4.436

8.  Two saturable recognition sites for (-) [125I]iodo-N6-(4-hydroxyphenyl-isopropyl)-adenosine binding on purified cardiac sarcolemma.

Authors:  V Hausleithner; M Freissmuth; W Schütz
Journal:  J Recept Res       Date:  1986

9.  Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; J D Hartman; S J Hays; C C Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

10.  The rat testicular A1 adenosine receptor-adenylate cyclase system.

Authors:  G L Stiles; G Pierson; S Sunay; W J Parsons
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

View more
  10 in total

Review 1.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Coupling mode of receptors and G proteins.

Authors:  Peter Hein; Moritz Bünemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-02       Impact factor: 3.000

3.  Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling.

Authors:  K N Klotz; H Vogt; H Tawfik-Schlieper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

4.  Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node.

Authors:  D Dennis; K Jacobson; L Belardinelli
Journal:  Am J Physiol       Date:  1992-03

5.  Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro.

Authors:  A J Chesi; T W Stone
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

6.  Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding.

Authors:  M Freissmuth; E Selzer; W Schütz
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

7.  Expression of two human beta-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein.

Authors:  M Freissmuth; E Selzer; S Marullo; W Schütz; A D Strosberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.

Authors:  C Nanoff; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

9.  A1 adenosine receptors can occur manifesting two kinetic components of 8-cyclopentyl-1,3-[3H]dipropylxanthine ([3H]DPCPX) binding.

Authors:  V Casadó; J Mallol; R Franco; C Lluis; E I Canela
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

10.  A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.

Authors:  S P Alexander; A R Curtis; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.